To better understand why bone is lost in disorders like periodontal disease, it is necessary to understand the control mechanisms which regulate the formation of new bone. Osteoinduction is the term given to the technique where bone is induced to form when demineralized allogeneic bone or proteins from bone are implanted in nonosseous sites. We know very little about the factors in bone which initiate or sustain this osteoinductive stimulus. Several potent growth factors have now been identified in bone, many of which have already been shown to have activity against bone and isolated bone cells. The objective of this proposal is to establish whether these newly recognized factors play a role in the osteoinductive process. We hope this will provide insights into the role these factors play in bone formation. The approach we intend to use is to combine these factors with purified osteoinductive factor in a well characterized subcutaneous implant model for osteoinduction. Using three different modes of delivery, we will determine whether increased local concentrations of the factors are able to alter the pattern of bone formation we see. Particular attention will be paid to changes in the cells which populate the implant, the pattern of mineralization associated with bone formation, and the amount of bone which is induced to form. Quantitative evaluation of these and other parameters will allow an accurate judgement of any role these factors may play in the osteoinductive process. We also intend to correlate in vivo osteioinduction with in vitro responses in established bone cell lines. From these studies we hope to develop the basis for in vitro assays which are truly predictive of in vivo osteoinductive activity.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Zubery, Y; Dunstan, C R; Story, B M et al. (1998) Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect Immun 66:4158-62
Izbicka, E; Yoneda, T; Takaoka, Y et al. (1996) Identification of a novel bone/calcium metabolism-regulating factor in porcine pancreas. J Biol Chem 271:23230-4
Garcia, C; Boyce, B F; Gilles, J et al. (1996) Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 11:1619-27
Marra, F; Bonewald, L F; Park-Snyder, S et al. (1996) Characterization and regulation of the latent transforming growth factor-beta complex secreted by vascular pericytes. J Cell Physiol 166:537-46
de la Mata, J; Uy, H L; Guise, T A et al. (1995) Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 95:2846-52
Hughes, D E; Wright, K R; Uy, H L et al. (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-87
Boyce, B F; Wright, K; Reddy, S V et al. (1995) Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts. Endocrinology 136:5751-9
Mundy, G R (1994) Peptides and growth regulatory factors in bone. Rheum Dis Clin North Am 20:577-88
Harris, S E; Bonewald, L F; Harris, M A et al. (1994) Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-63
Yoneda, T; Takaoka, Y; Boyce, B F et al. (1994) Extracts of porcine pancreas prevent progression of hypercalcemia and cachexia and prolong survival in nude mice bearing a human squamous carcinoma. Cancer Res 54:2509-13

Showing the most recent 10 out of 58 publications